
TAE Life Sciences, Ohio State University partner to advance cancer drug development
TAE Life Sciences (TLS) has signed a letter of intent with the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) to develop boron-based drug compounds for precision …